Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2026 16:20 ET | Source: Purple Biotech Ltd.

Purple Biotech Announces Plan to Implement ADS Ratio Change

ADS Will Begin Trading Reflecting the Ratio Change on March 2, 2026 REHOVOT, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the "Company") (NASDAQ/TASE: PPBT), a...
February 25, 2026 08:00 ET | Source: BrainsWay

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

BURLINGTON, Mass. and JERUSALEM, Feb. 25, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
February 25, 2026 06:00 ET | Source: Tower Semiconductor

Salience Labs and Tower Semiconductor Partner to Manufacture At-Scale Optical Circuit Switches for Next-Generation Data Centers

Salience Lab’s Innovative Architecture leverages Tower’s differentiated Silicon Photonics platforms to deliver ultra-low latency, high-bandwidth and lower-power optical connectivity for AI clusters ...
February 24, 2026 19:01 ET | Source: PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd. Completes the Reset of a $356.5 Million Securitization, Substantially Reducing Borrowing Costs

MIAMI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that PennantPark CLO VIII, LLC, a wholly-owned and consolidated...
February 24, 2026 16:30 ET | Source: Teva Pharmaceutical Industries Ltd

Teva to Present at the Upcoming Investor Conferences in March

PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO,...
February 24, 2026 07:13 ET | Source: Gilat Satellite Networks Ltd.

Gilat Receives $39 Million in Orders for Sidewinder ESA Terminals

New orders for Linefit and Retrofit installations underscore rising global demand for Gilat’s advanced Multi Orbit ESA technology PETAH TIKVA, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gilat...
February 23, 2026 08:00 ET | Source: BrainsWay

BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day

BURLINGTON, Mass. and JERUSALEM, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...
February 20, 2026 16:05 ET | Source: Foresight Autonomous Holdings Ltd.

Foresight Announced ADS Ratio Change

Ness Ziona, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, today...
February 20, 2026 14:43 ET | Source: Teva Pharmaceutical Industries Ltd

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address...
February 19, 2026 07:30 ET | Source: BrainsWay

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

BrainsWay continues to actively evaluate similar investments in leading North American mental health providers to raise awareness and expand access to transformative care BURLINGTON, Mass. and...